Millennium Management’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.8K | Buy |
+12,315
| New | +$88.8K | ﹤0.01% | 3831 |
|
|
2024
Q3 | – | Sell |
-1,195
| Closed | -$10.5K | – | 4069 |
|
|
2024
Q2 | $10.5K | Sell |
1,195
-3,231
| -73% | -$28.3K | ﹤0.01% | 3870 |
|
|
2024
Q1 | $108K | Buy |
4,426
+3,278
| +286% | +$80.3K | ﹤0.01% | 3804 |
|
|
2023
Q4 | $19.1K | Sell |
1,148
-2,524
| -69% | -$41.9K | ﹤0.01% | 3904 |
|
|
2023
Q3 | $68.6K | Sell |
3,672
-3,363
| -48% | -$62.8K | ﹤0.01% | 3839 |
|
|
2023
Q2 | $171K | Sell |
7,035
-9,100
| -56% | -$221K | ﹤0.01% | 3756 |
|
|
2023
Q1 | $353K | Buy |
16,135
+1,282
| +9% | +$28K | ﹤0.01% | 3585 |
|
|
2022
Q4 | $354K | Buy |
14,853
+1,568
| +12% | +$37.4K | ﹤0.01% | 3808 |
|
|
2022
Q3 | $365K | Sell |
13,285
-5,291
| -28% | -$145K | ﹤0.01% | 4068 |
|
|
2022
Q2 | $562K | Buy |
+18,576
| New | +$562K | ﹤0.01% | 3807 |
|
|
2022
Q1 | – | Sell |
-925
| Closed | -$275K | – | 5118 |
|
|
2021
Q4 | $275K | Sell |
925
-1,873
| -67% | -$557K | ﹤0.01% | 4469 |
|
|
2021
Q3 | $1.09M | Buy |
+2,798
| New | +$1.09M | ﹤0.01% | 3559 |
|
|
2021
Q2 | – | Sell |
-1,303
| Closed | -$741K | – | 4953 |
|
|
2021
Q1 | $741K | Buy |
+1,303
| New | +$741K | ﹤0.01% | 3419 |
|